We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+5.17%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$22B
AUM Growth
-$1.91B
Cap. Flow
-$2.72B
Cap. Flow %
-12.33%
Top 10 Hldgs %
10.77%
Holding
2,414
New
528
Increased
533
Reduced
664
Closed
678

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$229M
2
AA icon
Alcoa
AA
+$206M
3
V icon
Visa
V
+$130M
4
DRI icon
Darden Restaurants
DRI
+$127M
5
NTRS icon
Northern Trust
NTRS
+$127M

Sector Composition

Rank Sector Weight
1 Financials 17.13%
2 Consumer Discretionary 13.37%
3 Technology 9.27%
4 Industrials 7.54%
5 Real Estate 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMCH
2301
DELISTED
BMC Stock Holdings, Inc
BMCH
-680,101
Closed -$13.3M
GLIBA
2302
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
-8,321
Closed -$440K
DNKN
2303
CALL
DELISTED
Dunkin' Brands Group, Inc.
DNKN
-100,000
Closed -$5.97M
FRAN
2304
DELISTED
Francesca's Holdings Corporation
FRAN
-837
Closed -$48K
BSTC
2305
DELISTED
BioSpecifics Technologies Corp.
BSTC
-4,604
Closed -$204K
MYOK
2306
CALL
DELISTED
MyoKardia, Inc. Common Stock
MYOK
-40,000
Closed -$1.95M
CBL
2307
DELISTED
CBL& Associates Properties, Inc.
CBL
-733,930
Closed -$3.06M
ADSW
2308
DELISTED
Advanced Disposal Services Inc
ADSW
-11,291
Closed -$252K
HTZ
2309
DELISTED
Hertz Global Holdings, Inc.
HTZ
-3,723,941
Closed -$60.3M
AIMT
2310
CALL
DELISTED
Aimmune Therapeutics
AIMT
-378,700
Closed -$12.1M
AMTD
2311
CALL
DELISTED
TD Ameritrade Holding Corp
AMTD
-30,000
Closed -$1.78M
AMTD
2312
DELISTED
TD Ameritrade Holding Corp
AMTD
-276,852
Closed -$16.4M
INWK
2313
DELISTED
InnerWorkings, Inc.
INWK
-15,129
Closed -$137K
CCMP
2314
DELISTED
CMC Materials, Inc. Common Stock
CCMP
-2,593
Closed -$278K
ENT
2315
DELISTED
Global Eagle Entertainment Inc.
ENT
-2,036
Closed -$75K
BGG
2316
DELISTED
Briggs & Stratton Corp.
BGG
-35,265
Closed -$755K
PTLA
2317
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-15,449
Closed -$505K
PTLA
2318
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-75,000
Closed -$2.45M
TECD
2319
DELISTED
Tech Data Corp
TECD
-138,406
Closed -$11.8M
CHK
2320
DELISTED
Chesapeake Energy Corporation
CHK
-3,695
Closed -$2.23M
CSFL
2321
DELISTED
CenterState Bank Corporation Common Stock
CSFL
-25,613
Closed -$680K
JCP
2322
DELISTED
J.C. Penney Company, Inc.
JCP
-120,797
Closed -$341K
AGN
2323
CALL
DELISTED
Allergan plc
AGN
-75,000
Closed -$12.6M
RRTS
2324
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
-621
Closed -$39K
RARX
2325
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
-28,997
Closed -$154K

Similar funds

Balyasny Asset Management's Q2 2018 Portfolio in Review

As of Q2 2018, Balyasny Asset Management held 2,414 positions worth $22B, down 8% from $23.9B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Balyasny Asset Management withdrew a net $2.72B in Q2 2018, closing 678 positions and reducing 664 holdings. Its most notable exit was Burlington, an estimated $114M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Balyasny Asset Management opened a new position in Evergy worth $156M.

  • Balyasny Asset Management's largest Q2 2018 buy was Evergy: 2,779,050 shares worth $156M.
  • Balyasny Asset Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $366M increase.
  • Balyasny Asset Management's biggest Q2 2018 reduction was Walt Disney, cutting an estimated $229M.
  • Balyasny Asset Management fully exited Burlington in Q2 2018, selling an estimated $114M.
  • Balyasny Asset Management's ten largest holdings make up 11% of its $22B portfolio in Q2 2018.
  • Balyasny Asset Management opened 528 new positions and closed 678 in Q2 2018.
  • Balyasny Asset Management's portfolio value fell 8% quarter-over-quarter to $22B.

Based on Balyasny Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.